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The Crystal Structure of H-2Dd MHC Class I Complexed
with the HIV-1-Derived Peptide P18-I10 at 2.4 AÊ Resolution:
Implications for T Cell and NK Cell Recognition
which can activate T lymphocytes. Each allelic form of
an MHC class I molecule is capable of binding a diverse
series of peptides, and this capacity, coupled with varia-
tions in the peptide binding specificities of the different
alleles, generates the broad sampling of peptide epi-
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HLA-A2 was the first crystal structure of an MHC com-and Biophysics
plex to be determined (Bjorkman et al., 1987a, 1997b),³Center for Molecular Medicine
soon followed by the structures of murine and humanKarolinska Hospital
MHC molecules complexed with single peptides (re-Stockholm
viewed in Jones, 1997). However, the structure of H-2DdSweden
is unknown. A structural analysis of this particular MHC§UmeaÊ Center for Molecular Pathogenesis
class I molecule is important for several reasons. First,UmeaÊ University
sequencing of peptide pools eluted from H-2Dd (CorrUmeaÊ
et al., 1993; Rammensee et al., 1995) has revealed anSweden
unusual type of peptide binding motif, requiring three
principal anchor residues (p2G, p3P, and p10I/L/F) and
a very strong secondary anchor position in the middleSummary
of the peptide (p5R/K/H). Second, the H-2Dd molecule
has been extensively used in functional analysis of TThe structure of H-2Dd complexedwith the HIV-derived
cell recognition, particularly in presentation of the P18-peptide P18-I10 (RGPGRAFVTI) has been determined
I10 peptide RGPGRAFVTI from the V3-loop of the gp160by X-ray crystallography at 2.4 AÊ resolution. This MHC
HIV-1 protein. This peptide sequence may be of particu-class I molecule has an unusual binding motif with
lar interest in comparative structural studies since itfour anchor residues in the peptide (G2, P3, R/K/H5,
displays ªpromiscuousº binding to four different murineand I/L/F9 or 10). The cleft architecture of H-2Dd in-
(H-2Dd, H-2Dp, H-2u, and H-2q; Shirai et al., 1992) and atcludes a deep narrow passage accomodating the
least one human (HLA-A2; Alexander-Miller et al., 1996)N-terminal part of the peptide, explaining the obliga-
MHC class I molecules. Furthermore, there are CTL (cy-tory G2P3 anchor motif. Toward the C-terminal half of
totoxic T lymphocyte) clones that can respond to thethe peptide, p5R to p8V form a type I9 reverse turn;
peptide whether it is presented by H-2Dd, H-2Dp, or H-2uresidues p6A to p9T, and in particular p7F, are readily
class I molecules (Shirai et al., 1993, 1996, 1997). Theexposed. The structure is discussed in relation to func-
structure of H-2Dd complexed with P18-I10 may help totional data available for T cell and natural killer cell
define the structural basis for this ªdegeneracyº of therecognition of the H-2Dd molecule.
MHC specificity and cross-reactivity of T cell responses.
Finally and most importantly, the H-2Dd molecule rep-Introduction
resents the prototype ligand for the best characterized
natural killer (NK) cell receptor, Ly-49A. It is now clear
Class I major histocompatibility complex (MHC) mole-
that MHC class I molecules play an important role in
cules are plasma membrane proteins expressed by vir-
the regulation of NK cell activity (KaÈ rre, 1985; KaÈ rre et al.,
tually all mammalian cells. They transport peptides to
1986; Ljunggren and KaÈ rre, 1990; Gumperz and Parham,
the cell surface for presentation to T cells of the immune 1995). Novel types of inhibitory receptors on NK cells
system. MHC class I molecules are composed of two
can recognize MHC class I complexes (Karlhofer et al.,
subunits: the polymorphic membrane-anchored heavy
1992; Moretta et al., 1993; Litwin et al., 1994; Long et
chain (with extracellular domains a1, a2, and a3) and a al., 1997; Ryan and Seaman, 1997). Expression of an
lighter invariant soluble noncovalently attached b2-micro- appropriate MHC class I molecule on the surface of a
globulin (b2m) unit. The third component of the MHC cell will prevent its destruction by NK cells through an
complex is an 8- to 11-amino acid±long peptide posi- inhibitory effect following the engagement of the target
tioned in a cleft formed by the a1 and b2 domains of the cell MHC molecule by the NK cell receptor. In the mouse,
heavy chain. this is mediated by receptors of the Ly-49 family within
Recognition of peptides complexed to MHC mole- the superfamily of C-type lectins. Ly-49A can recognize
cules by T cell receptors is a critical event in initiation H-2Dd, H-2Dk, and H-2Dp molecules but not any of the
of an immune response (Zinkernagel and Doherty, 1974; allelic MHC class I products that have been crystallized
Haskins et al., 1984; Townsend et al., 1986; Bjorkman to date (Karlhofer et al., 1992; Brennan et al., 1994;
and Parham, 1990). Invasion of a cell by a pathogen Daniels et al., 1994a; Kane, 1994; Sentman et al., 1994;
results, in most cases, in presentation of non-self-anti- Alheim-Olsson and KaÈ rre, unpublished data). Inhibitory
gens on the cell surface by MHC class I molecules, recognition by Ly-49A maps to the a1a2 domains of the
MHC class I ligand (Karlhofer et al., 1992; SundbaÈ ck et
al., 1998); it requires that the H-2Dd molecule has bound‖ To whom correspondence should be addressed (e-mail: klas.karre
a peptide, but there is no specificity since any peptide@mtc.ki.se).
# These authors contributed equally to this work. bound to H-2Dd will permit recognition (Correa and
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residues 132±152 in the a2 domain, have weak electron
density, reflecting higher than average flexibility for this
part of the molecule. However, the electron density for
all residues in contact with the peptide is clearly defined.
The orientation of the b2m subunit with respect to the
heavy chain was analyzed with the TOP program (Lu,
1996) and compared to other MHC class I complexes.
The orientation of the b2m chain in the H-2Dd structure
is very similar, within 2 to 48, to that of H-2Db and the
human MHC class I molecules. A significantly larger dif-
ference in this respect was apparent between H-2Dd
and H-2Kb; the orientation of the b2m subunits deviates
by approximately 108 in these two MHC class I mole-
cules. The hydrogen bonding pattern and van der Waals
contacts between b2m and the H-2Dd heavy chain were
compared with the corresponding interactions in H-2Db,
H-2Kb, and H-2Ld (Young et al., 1994; Balendiran et al.,
1997). The number of intersubunit contacts in H-2Dd is
comparable to that found in H-2Db (data not shown).
This correlates with the higher stability of these class I
molecules as compared to H-2Ld, which exhibits muchFigure 1. Schematic View of the H-2Dd Complex
fewer contacts (Balendiran et al., 1997).The a and b chains are depicted in red and blue, respectively. The
bound P18-I10 decapeptide is shown in a ball and stick representa-
tion. The figure was created using the Molscript program (Kraulis, Conformation and Length of the Bound
1991). PeptideÐInfluence of Unusual Features
of the H-2Dd Binding Cleft
While peptides binding to H-2Kb and H-2Db are 8±9
Raulet, 1995; Orihuela et al., 1996). Ly-49A can bind to amino acids long, those that bind to H-2Dd (with a few
different sugars (Daniels et al., 1994b), but the carbohy- exceptions) areat least nine amino acids long, and many
drates of the MHC class I molecule are not necessary of them are decamers (Corr et al., 1993). The conforma-
for the recognition of H-2Dd by Ly-49A (Matsumoto et tion and minimal length of peptides bound by an MHC
al., 1998). class I molecule is determined by the distance between
The purpose of this study was to establish a structural the two hydrogen bonding networks used for anchoring
basis for understanding the various interesting functional of the peptide N and C termini and by the mid-cleft
features of the H-2Dd molecule. We have employed a architecture (Bouvier and Wiley, 1994; Young et al.,
bacterial expression system and in vitro complex forma- 1995). The H-2Dd peptide binding cleft can be divided
tion for crystallization of H-2Dd with the HIV-1 peptide into three regions (Figure 3): a narrow deep cleft binding
RGPGRAFVTI (Achour et al., 1998). We now report the the N-terminal part of the peptide, a more shallow broad
crystal structure at 2.4 AÊ resolution, and the refined mid-cleft depression over which amino acids 5±9 of the
model is analyzed with respect to peptide binding and peptide are positioned, and the characteristic deep hy-
T cell and NK cell recognition. drophobic F pocket. The first two regions of the cleft
are separated by the simultaneous presence, unique for
Results and Discussion H-2Dd (Watts et al., 1989), of two tryptophans at posi-
tions W97 and W114. The tryptophan residues create a
Overall Structure of the H-2Dd Complex wall that the peptide has to climb from the deep cleft
The overall backbone structure of the recombinant H-2Dd to the shallow part of the binding cleft (Figure 3). This
is presented in Figure 1. As expected from the high plateau harbors an auxiliary anchor position at p5, forc-
degree of sequence identity, it is very similar to the ing the remainder of the peptide to arch out of the cleft
previously reported mouse and human MHC crystal before anchoring at the C terminus. This architecture
structures, e.g., the r.m.s. deviation between H-2Dd and requires a minimum of a nonamer for binding; five resi-
the crystal structure of H-2Db (Young et al., 1994) for all dues are needed to reach from the N terminus over the
Ca atoms in the heavy chain and the b2m subunit is 1.23 wall to the p5 anchor position and then four amino acids
AÊ as calculated with the O program (Jones et al., 1991). to reach the F pocket.
The structure was determined by molecular replacement Figures 2A and 3 depict the conformation of the pep-
using X-ray diffraction data to 2.4 AÊ resolution. The R tide (RGPGRAFVTI) when bound to H-2Dd. It binds in
value for the refined model with good stereochemistry the cleft along the a1-helix in a hitherto unobserved con-
is 27.8%, and Rfree is 32.3%. The final electron density formation. The N terminus binds strongly through hydro-
map is of excellent quality (Figure 2) despite a high gen bonds to the side chains of Y171 and Y7 in the A
average B factor in the crystals. There are no ambiguities pocket, and the C-terminal is anchored by a network of
in the structure, except for a few surface side chains. hydrogen bonds formed by Y84, T143, and K146 in the
The residues that constitute the CD8 binding part of F pocket (Table 1), similarly to other peptides in MHC
the a3 domain (amino acids 220±229) (Gao et al., 1997), class I complexes (Madden, 1995; Young et al., 1995).
However, the peptide residues p5R top8V form a reverseresidues 105±107, and parts of the region comprising
Crystal Structure of the H-2Dd Complex
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Figure 2. Conformation of the Bound Peptide
(A) Side view of the peptide RGPGRAFVTI colored according to atom type in a sA-weighted |Fo-Fc| annealed omit map at 2s contour level.
The peptide N terminus to C terminus main chain direction runs left to right, illustrating the anchor positions (perpendicular arrows) and the
emerging side chains that can interact with, e.g., T cell receptors. The part of the peptide that protrudes above the surface of the protein is
indicated by the horizontal arrows on each side of the peptide. The figure was created using the O program (Jones et al., 1991).
(B) Residues P5R to P8V of the bound peptide, illustrating the reverse type I9 turn in the peptide. The phi, psi angles and the hydrogen bond
characteristic for this type of turn are indicated.
turn of type I9 over the mid-cleft depression (Figure 2B). The presence of this b-turn probably confers additional
stability to bound decamer peptides that have to bulgeIn general, such turns are characterized by four consec-
utive residues, often with a hydrogen bond between the between p5R and p10I anchor binding locations. It is
probably not required for the binding of nonamers andmain chain atoms of residue i and i 1 3. The type of
turn is defined by the pair of phi/psi angles of residues thus probably not a general feature of peptides bound
to H-2Dd.i 1 1 and i 1 2 (Wilmot et al., 1990). The turn of the
bound peptide is stabilized by a hydrogenbond between
the carboxyl group of p5R and the amino group of p8V. Structural Features Explaining the Shared Motif
of H-2Dd Binding PeptidesThe phi and psi values of the residues located in between
p6A and p7Fare 588/188 and 638/328, respectively,corre- The architecture of the H-2Dd binding cleft explains the
unusual motif with four anchor positions used by pep-sponding to a b-turn of type I9 (g g ). As a consequence
of this structural feature, residues p6A to p9T and in tides for binding (Corr et al., 1993). The peptide binds
to the cleft through two anchor positions on each sideparticular p7F are exposed to solvent (Figures 2 and 3).
Figure 3. The Peptide P18-I10 (RGPGRAF
VTI) Bound to the Cleft of the MHC Class I
H-2Dd Molecule
The peptide is represented as a stick model,
while the MHC class I molecule is repre-
sented by its surface (viewed from above).
The regions specific for the binding of differ-
ent sections of the peptide are displayed. The
position of H-2Dd residues important for the
binding of P18-I10 and a few other residues
are indicated. Negatively charged regions of
the surface are given in red and positively
charged regions in blue, with a scale from
215 kT to 115 kT. Peptide residue labels be-
gin with p. It should be noted that R62 and
E163 do not form significant electrostatic in-
teractions; the closest distance betweentheir
side chains is 4.9 AÊ . This figure was created
using the Grasp program (Nicholls et al.,
1991).
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Table 1. Hydrogen Bond (,3.2 AÊ ) and van der Waals (,3.6 AÊ ) Interactions of the Decapeptide P18±I10 with Residues of the Cleft in
the H-2Dd Complexa
Hydrogen Bonding
Peptide Residue Atom Atom H-2Dd-residue Van der Waals Contactsb
p1R N OH Y171 W167 (5), R62 (11),
N OH Y7 E63 (1), E163 (2), Y7 (6),
O OH Y159 Y159 (3), Y171 (4)
NH1 OE1 E163
p2G N OE1 E63 Y7 (4), E63 (1), R66 (7),
Y159 (2)
p3P O NH1 R66 R66 (3), Y159 (1),
W97 (1), N70 (1)
O ND2 N70
p4G O NH2 R155 R155 (4)
p5R N OD1 N70 N70 (2), D77 (2)
NH1 Wat32 Wat32 (2)
NH2 OD2 D77
p6A None None
p7F None None
p8V None W147(2)
p9T O NE1 W147 V76 (1), D77 (4),
W147 (4)
p10I N OD1 D77 D77 (8), Y84 (4),
O OG1 T143 T143 (4), K146 (2)
O OH Y84
OXT NZ K146
a The analysis was performed with the Contacts program contained in the CCP4 suite (CCP4, 1994).
b Contacts of ,3.6 AÊ between peptide and H-2Dd are listed with their numbers in parentheses.
of the tryptophan wall. Anchor positions p2G and p3P Proline, the second essential amino acid for binding
of the peptide (Corr et al., 1993; Takeshita et al., 1995),of the peptide bind in the deep N-terminal cleft, the
basic residue p5R binds to the shallow, predominantly is buried in the hydrophobic pocket formed by Y7, V9,
W97, A99, W114, and Y159 (Figure 4B). No part of itsnegatively charged depression, and the hydrophobic
amino acid p10I at the C-terminal end of the peptide side chain is accessible to the solvent. The proline ring
stacks to the ring of Y159, the conformation of the tyro-binds in the F pocket, similarly to pC-terminal binding
in several other MHC class I molecules (Madden, 1995). sine being stabilized through a hydrogen bond from its
hydroxyl to the carbonyl oxygen of p1R. The backboneOf the 182 residues in the a1/a2 domain of the H-2Dd
molecule, 15 interact through a hydrogen bond with the carbonyl of p3P binds strongly through two hydrogen
bonds to R66 and N70.peptide. In addition, the peptide forms a large number
of van der Waals interactions to protein atoms (Table The c value of the GP peptide bond lies in the b-region
at around 1808 in the Ramachandran plot. Any other c1). The reverse turn conformation of the P18-I10 peptide
also gives rise to internal interactions between residues value would result in a steric clash against either R66
and E63 or Y159. The GP motif is thus necessary towithin the peptide (data not shown).
The Structure of the Deep, Narrow pN-Terminal provide a perfect fit for the peptide to the deep and
narrow N-terminal cleft. Besides providing specific bind-Part of the Cleft Explains the Requirement
for p2Gp3P in the Peptide ing interactions as described above, p3P restrains the
conformational freedom of the glycine anchor positionBoth p2G and p3P are required for the peptide to bind;
a mutation of either one of these amino acids impairs (p2G) that precedes it. At the same time, this part of the
peptide has a conformation, often adopted by GP unitsbinding to the H-2Dd molecule (Takeshita et al., 1995).
The H-2Dd crystal structure explains this obligatory mo- (MacArthur and Thornton, 1991), that allows the re-
maining part of the peptide to ascend the wall createdtif; the GP combination at positions 2 and 3 is necessary
for the peptide to meet the steric constraints in the cleft by W97 and W114 to the shallow part of the cleft.
p5R Binds in the Shallow and Broad Depression(Figures 3 and 4). The passage between R66 and E63
on the a1-helix and Y159 on the a2-helix is very narrow The cleft broadens in the shallow part of the binding
groove between S73, D77, and D156. By contrast todue to the side chain of R66 in the a1 helix that projects
down into the cleft. It interacts with the side chains of MHC class I molecules H-2Db (Young et al., 1994) and
H-2Ld (Balendiran et al., 1997), there is no hydrophobicE24, Y45, and E63 and fills theB pocket normally present
in other MHC class I molecules (Madden, 1995; Young ridge crossing the cleft (Figure 5). The side chain of
anchor position 5 rests on the shallow depression, a flatet al., 1995). As a direct consequence of this narrow
passage, no amino acid other than glycine can be al- plateau formed by W114, W97, F116, and F74 from the
a1-helix and W147 from the a2-helix (Figure 3). The posi-lowed at this position of the peptide (Figure 4A). The
glycine perfectly fills the cleft, leaving only 5% of its tively charged guanidinium group of p5R interacts with
the side chain of D77 (Table 1) and possibly through asurface available to the solvent (4 AÊ 2). A mutation, e.g.,
to alanine, would result in a steric clash with the side net of hydrogen-bonded water molecules with D156.
p5R also forms a hydrogen bond from its main chainchain of R66.
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H-2Dd, the F pocket is wider than usual due to the pres-
ence of an alanine at position 81, in contrast to a leucine
in most of the H-2 molecules (Watts et al., 1989).
Peptide Side Chains Protrude Toward the Solvent
in Two Regions
Two parts of the peptide are exposed to solvent, the
side chain of p1R and, more prominently, residues p6A,
p7F, p8V, and p9T over the shallow and broad part of
the binding groove (Figures 2 and 3). A study of the
peptides eluted from H-2Dd complexes reveals a great
diversity of amino acids in both regions (Corr et al.,
1993).
The side chain of p1R projects out into the solvent
(11% accessibleto the solvent, 34AÊ 2) and is held through
planar stacking interactions with R62 and the aromatic
side chain of W167 and through a hydrogen bond with
E163. This part of the binding cleft is wide enough to
accomodate other side chains.
The second part of the peptide that protrudes out of
the cleft comprises positions p4G (21% solvent accessi-
bility, 15 AÊ 2), p6A (68%, 54 AÊ 2), p7F (75%, 151 AÊ 2), p8V
(42%, 39 AÊ 2), and p9T (26%, 30 AÊ 2). The side chains of
the phenylalanine at position 7 and the threonine at
position 9 are directed toward the a1 part of the binding
cleft, while the alanine at position 6 and the valine atFigure 4. Interaction of the GP Anchor Motif in the Binding Cleft
position 8 are directed towards the a2-helix (Figure 3).(A) p2G is the only amino acid that fits in the narrow passage be-
On the a2 part of the binding cleft, p6A is exposed totween R66 and Y159. The van der Waals surfaces of R66 and Y159
are colored in blue, while the van der Waals surface of p2G is colored the solvent but makes hydrophobic interactions with the
in gray (section across the cleft, viewed from the C terminus of the side chains of R155 and the side chain of p8V. The side
peptide). chain of p8V forms hydrophobic interactions to a cluster
(B) The side chain of p3P is situated in a hydrophobic pocket formed
composed by the side chains of W147, A150, and A152.by the side chains of V9, W97, A99, W114, and Y159 that stacks
p8V also forms internal main chain/main chain and mainwith its aromatic ring to p3P. The carbonyl of p3P binds through
chain/side chain hydrogen bonds to p5R. On the a1 sidehydrogen bonds (depicted as broken lines) to the side chains of
R66 and N70. The figure was created using the Grasp program of the binding cleft, p7F covers all or parts of the side
(Nicholls et al., 1991). The color of the atoms is red for oxygen, blue chains of G69, N70, and S73. The exposed side chain
for nitrogen, and white for carbon. of p9T forms a hydrophobic interaction with the side
chain of V76, while its main chain carbonyl interacts
through a hydrogen bond to the side chain of W147.
amino group to the side chain oxygen of N70. The side
The crystal structure is not consistent with the model
chain of this auxiliary anchor position is entirely covered
of the MHC class I H-2Dd/P18-I10 complex that has been
by the remaining part of the peptide that bulges out over
suggested previously (Corr et al., 1993) and that has
it, with the four following residues more or less exposed
been used for interpretation of functional data (Take-to the solvent. Only 3% of p5R is accessible to the
shita et al., 1995; Shirai et al., 1997; Matsumoto et al.,solvent (5 AÊ 2). p5R also forms internal hydrogen bonds
1998). These differences include (1) the way in whichto side and main chain atoms of the peptide (Figure 2B;
the peptide binds, e.g., p5R binds to D77 on the a1data not shown). This anchor position does not bind in
domain and not, as proposed in the model, to D156 ona deep pocket, which may explain why the peptide is
the a2 domain; (2) spatial position of side chains, e.g.,still able to bind when p5R is mutated to an alanine
R66, a central amino acid in the binding of p2G, projects
(Takeshita et al., 1995). p5R, H or K as in some other
down in the crystal structure while it has been proposed
H-2Dd binding peptides, can thus be classified as a sec-
to build a bridge over the P18-I10 peptide in the model;
ondary anchor position (Corr et al., 1993) that helps to
and (3) the way by which different potential epitopic side
stabilize the nonameric and decameric peptides in their
chains of the peptide are presented, e.g., p7F is exposed
binding to H-2Dd, particularly through their interaction
to the solvent and does not participate in binding of the
with the side chain of D77.
peptide to the groove.P10I Binds in the Hydrophobic F Pocket
The last anchor residue is a hydrophobic residue in
accordance with the usual motif described in murine Implications of the Structure for Interpretation
of Studies of Peptide BindingMHC class I molecules (Falk et al., 1991; Rammensee
et al., 1995). In this case, it is an isoleucine that binds and T Cell Recognition
Functional studies (Takeshita et al., 1995), using alanine-deeply (0% solvent accessibility) into the hydrophobic
F pocket formed by residues Y123, F116, I124, W147, substituted P18-I10 peptide variants, revealed that posi-
tion p10I seemed to be the most critical for binding toL95, and Y84, but the peptide can also have a leucine
or a phenylalanine (Corr et al., 1993) at this position. In H-2Dd, followed by p2G, p3P, and p5R. This sequence of
Immunity
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Figure 5. Differences in Side Chain Compo-
sitions of the H-2Dd and H-2Db a1a2 Regions
(A) and (B) depict H-2Dd and H-2Db, respec-
tively. On the right part of the figure, the back-
bone of both MHC class I molecules is repre-
sented as a rod with only differences in side
chains depicted. The latter are colored as fol-
lows: red for oxygen, blue for nitrogen, white
for carbon, and yellow for sulfur. This part of
the figure was created using the Setor pro-
gram (Evans, 1993). On the left side, using
the Grasp program (Nicholls et al., 1991), the
differences between H-2Dd and H-2Db in the
resulting architecture in the a1a2 region are
illustrated. Color and scale as in Figure 3.
Interesting regions in both MHC class I mole-
cules are depicted by arrows. The figures of
H-2Db were based on the crystal structure
resolved by Young et al. (1994).
critical residues agrees with the motif already described p5R difficult. In conclusion, analysis of the H-2Dd crystal
structure combined with sequence comparisons indi-(Corr et al., 1993) and with the crystal structure of the
complex presented here; all four anchor residues be- cates that the peptide has to bind in a different manner
in the three other MHC class I molecules.come buried upon binding to H-2Dd providing large and
specific binding energy. Positions 1, 4, 6, 7, 8, and 9 are In spite of this, there are examples of CTL clones that
cross-react with respect to the restriction element, i.e.,exposed to the solvent. The most prominent of these
residues, at positions 6, 7, and 8 of the peptide, have they can recognize the peptide presented by different
class I molecules (Shirai et al., 1992, 1997). Crystal struc-all been demonstrated to be T cell epitopic positions in
the context of H-2Dd (Takahashi et al., 1989a, 1989b, tures of TCR complexed with MHC class I molecules
(Garboczi et al., 1996; Garcia et al., 1996) reveal that1992; Shirai et al., 1992, 1997; Takeshita et al., 1995).
The substitution of p7F to an alanine did not impair the TCR simultaneously contacts residues on both the
peptide and the MHC molecule. In the case of P18-I10binding or recognition by specific T cells, while substitu-
tion of the same position to an isoleucine prevented recognition, this could mean that the cross-recognizing
TCR binds a part of the MHC class I molecule that isrecognition (Takeshita et al., 1995). From the structure,
we can conclude that this is not due to loss of binding highly conserved between all of the cross-reacting al-
leles (H-2Dd, H-2Dp, and at least one of the class I locusof the peptide to H-2Dd but must be due to impaired
interactions with the TCR. products of the H-2u haplotype) or that it is extremely
sensitive to some side chains from the peptide such asThe promiscuous MHC binding observed with the de-
camer P18-I10 (Shirai et al., 1992) implies that this pep- p7F. These two possibilities are not mutually exclusive,
and there is support for both of them. First, a studytide may possess structural features that confer broad
binding specificity. No consensus peptide motif is based on single amino acid substitutions of P18-I10
identified P7F, followed by p8V and p9T, as key residuesknown for H-2Dp, H-2u, and H-2q class I molecules. It is
highly probable, however, that P18-I10 binds to these in the recognition of P18-I10 presented by H-2Dd, H-2Dp,
and by H-2u class I molecules (Shirai et al., 1997). Sec-MHC molecules in a different manner than to H-2Dd,
since many of the residues responsible for the binding ond, a comparison of the amino acid sequences for
H-2Dd and H-2Dp reveals interesting conserved regions,of the anchor positions of P18-I10 differ between H-2Dd
and thecross-binding MHC class I molecules. For exam- and the crystal structure indicates that they are all close
to p7F. For example, E71, Q72, R75, and R79 are com-ple, position R66, important in forming the binding
pocket for p2G and p3P in the case of H-2Dd, is occupied mon to the two class I molecules and could thus be
involved in the cross-recognition. There may be corre-by asparagine and isoleucine, respectively, in the case
of H-2Dp and H-2D/Lq. Furthermore, residue A99, unique sponding regions on the TCR side, since there is a pref-
erential usage of Vb8 in T cell clones recognizing P18-for H-2Dd and important for the binding of p3P, is re-
placed by an arginine in the case of H-2Dp and a tyrosine I10 in H-2Dd, H-2Dp, and H-2u (Shirai et al., 1993). In
conclusion, residues of the class I molecule and the p7Fin the case of H-2Dq and H-2Lq. The important middle
wall composed by W97 and W114 in H-2Dd is replaced may form a ªsupermotif,º preferentially recognized by
TCR-Vb8. Whether or not the reverse type I9 b-turn isby G97 and E114 in H-2Dp and by R97 and E114 in H-2Dq
and H-2Lq. D156 is substituted for L156 in H-2Dp and present when the peptide is bound to H-2Dp and the
relevant class I product of H-2u, p7F might still be pre-Y156 in H-2Dq and H-2Lq, rendering the equivalent bind-
ing of a large positively charged amino acid such as sented to the T cell receptor in a similar way as in H-2Dd.
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Bidirectional cross-reactivity between the 15-mer pep- class I molecules, two potential regions for Ly-49A rec-
ognition have emerged: the N-terminal-central part oftide P18 and a nonhomologous gp160 15-mer peptide,
the peptide binding groove with adjacent areas and anHP53, has also been observed for CD81 CTL in strains
area around one of the N-specific glycosylation sitesexpressing H-2Dd. This phenomenon was mapped to
N176, including an external loop of the a2 domain.P18-I10 of P18 and to an eight-residue core of HP53,
Central a2 domain residues in the first region are A99,HP53-I8, VQGAYRAI (Shirai et al., 1996). In our analysis
W97, and W114, all involved in the binding of the doubleof the structure above, we have concluded that the cleft
p2Gp3P anchor position of the H-2Dd peptide. Thesearchitecture of H-2Dd requires at least nonameric pep-
polymorphisms are buried in the antigen binding groovetides, containing p2Gp3P as an obligatory motif, for
and can therefore not be directly contacted by a recep-binding from theA to the Fpocket. HP53-I8 isan octamer
tor; they can only affect the bound peptide. However,and lacks p2Gp3P. We therefore propose that this pep-
it should be noted that even if recognition does nottide binds with one sole anchor position p8I in the deep
require a specific peptide, it is still peptide-dependent,F pocket. P5Y would then be in an equivalent position to
and all peptides active in this respect contain thep7F in P18-I10, known tobe involved in TCR recognition,
p2Gp3P motif (Correa and Raulet, 1995; Orihuela et al.,and the structural similarity in these side chains could
1996). The principal difference between H-2Dd and H-2Dbthen explain the cross-reactivity. This would not require
in this part of the molecule is that the p2Gp3P motifthe presence of a type I9 b-turn. Ongoing structural stud-
assumes a very specific conformation and is deeplyies of other MHC class I molecules binding P18-I10 and
buried (Figures 2 and 4). The corresponding peptideHP53-I8 should help to better define the causes for this
residues in H-2Db or H-2Kb, both failing to bind Ly-49A,broad cross-recognition. It should be noted that among
are variable among binding peptides (Rammensee etpeptides eluted from H-2Dd, selected for strong binding
al., 1995), and the molecular profile toward the solventin vivo, 20 out of 22 contained the p2Gp3P motif (Corr
is consequently variable and different from H-2Dd in thiset al., 1993). Such peptides therefore appear superior
region. One possibility that reconciles available func-in competing for loading into H-2Dd molecules in vivo.
tional data with the structure presented here is that the
peptide may provide specificity not by exposing certainH-2Dd As a Ligand for the NK Cell Receptor
residues that can be engaged by the receptor but ratherLy-49AÐComparison with Other MHC
by avoiding exposure at positions 2 and 3, thereby alsoClass I Molecules
avoiding disturbance of receptor engagement close to
H-2Dd, H-2Dk, and H-2Dp act as ligands for inhibitory
this part of the groove.
recognition by the NK cell receptor Ly-49A, while H-2Kb,
Adjacent to this region, residues W73 and Y156 form
H-2Ld, H-2Kd, and H-2Db fail to do so or at best represent
a hydrophobic ridge in the H-2Db peptide binding cleft
weak ligands (Karlhofer et al., 1992; Kane, 1994; Ryan
that is absent in H-2Dd. This ridge is also missing in the
and Seaman, 1997; Takei et al., 1997; KaÈ rre, unpublished other Ly-49A ligands, H-2Dp and H-2Dk, but is present
data). Loading of H-2Dd molecules with the HIV-derived in the nonbinding ligand H-2Ld (Balendiran et al., 1997).
peptide RGPGRAFVTI, used by us for crystallization, At the position of the ridge in H-2Dd there is a plateau,
or any of eight other H-2Dd binding peptides enabled lined by the negatively charged D77 and D156 and the
recognition and inhibition through Ly-49A (Correa and tryptophans in positions 97 and 114. The ridge may
Raulet, 1995; Orihuela et al., 1996). Loading of H-2Db influence the binding of a receptor. In accordance with
molecules with the influenza-derived peptide ASNEN this notion, mutation of positions 73and 156 in the H-2Dd
METM did not result in inhibitory recognition by Ly-49A1 molecule impaired protection against Ly-49A1 cells, but
NK cells. only partially (WaldenstroÈ m et al., 1998). The absence
To investigate structural features important for MHC of this ridge is therefore not sufficient to allow Ly-49A
class I recognition by the NK cell receptor Ly-49A, we binding. This is also supported by the fact that this ridge
thus compared the H-2Dd/RGPGRAFVTI structure with is lacking in H-2Kb, which is not recognized by Ly-49A.
the published structure of H-2Db complexed to the pep- Continuous to this area is a region where H-2Dd and
tide ASNENMETM (Young et al., 1994) (Figure 5). We H-2Db differ significantly with contributions from the a1
will focus our discussion of this comparison on differ- as well as the a2 domains, including the variable residues
ences in the a2 domain (amino acids 90±182) of the 73, 77, 80, 81, 83, 119, and 121 (Figure 5). Some residues
molecule and particularly of its N-terminal part, for the of this region in the human (73, 77, and 80) are important
following reasons. A recent study based on H-2Dd/Db for the binding of immunoglobulin-like KIR (killer inhibi-
chimeric molecules has mapped allelic specificity of the tory receptors) molecules (Colonna et al., 1993a, 1993b;
Ly-49A receptor to the a2 domain of the H-2Dd molecule Cella et al., 1994; Gumperz et al., 1995; Luque et al.,
(SundbaÈ ck et al., 1998). Furthermore, 34-5-8S, the only 1996).
anti-H-2Dd antibody that is capable of blocking the in- The second region of interest for Ly-49A recognition
teraction between this MHC class I molecule and the lies beneath the a2-helix but is well exposed to the sol-
Ly-49A receptor, binds to residues 92 to 116 in the vent. It contains a cluster of residues (2, 103, 104, 107,
N-terminal part of the a2 domain (Abastado et al., 1987; and 169) that differ between H-2Dd and H-2Db and that
Karlhofer et al., 1992; Orihuela et al., 1996). form a loop in the N-terminal part of the a2-domain of
There are 31 differences altogether in the amino acid the H-2Dd structure. This region is near the glycosylation
sequences between the a1a2 domains of H-2Dd and site at N176. There is evidence that the carbohydrate
H-2Db (Watts et al., 1989); 13 of these are in the a2 at this site can contribute to binding by Ly-49A, even if
domain. In our analysis of these in relation to the struc- it does not appear to be necessary for functional recog-
nition and inhibition (Matsumoto et al., 1998).ture, as well as sequences and models of other MHC
Immunity
206
Conclusions Table 2. Data Collection and Refinement Statistics
The crystal structure of the H-2Dd/RGPGRAFVTI com-
Data collectionplex resolved at 2.4 AÊ reveals a cleft with one deep and
Resolution (AÊ ) 25.0±2.4narrow part, where the tandem anchor position p2Gp3P
Measured reflections 199263fits snugly with minimal solvent exposure, and one shal-
Unique reflections 20963low and broad part, where the C-terminal half of the
Completeness (%)peptide protrudes and is readily exposed before it an-
All data 96.5
chors deeply in the F pocket. The peptide first arches Highest resolution shell (2.46±2.40 AÊ ) 94.6
over a mid-cleft tryptophan wall and then further over RMerge (%)
All data 4.0the buried side chain of the secondary anchor position
Highest resolution shell 29.8p5R. In the case of P18-I10, residues p5R-p8V form a
I/s(I)type I9 reverse turn, exposing positions 6±9, particularly
All data 34.0p7F, to the T cell receptor. These results are consistent
Highest resolution shell 4.7
with several observations in functional studies of T cells Mosaicity (8) 0.61
recognizing the P18-I10 peptide. In addition, the struc-
Refinement Statistics
tural analysis suggests a motif comprising p7F and con-
Resolution (AÊ ) 20.0±2.4served residues in the a1 domain as a possible explana-
Unique reflections 17675tion for CTL clones that can recognize the peptide
Rcryst (%) 29.3 (27.8)awhether it is presented by H-2Dd or H-2Dp. Previous
Rfree (%) 33.8 (32.3)a
functional studies of NK cells have indicated that allelic No. of protein atoms 3146
specificity of the Ly-49A inhibitory receptor may be de- No. of waters 65
Average B-factor (AÊ 2)termined by polymorphisms in the N-terminal part of the
Protein 63.4a2-domain of H-2Dd. Based on the structure, we propose
Peptide 50.8two regions of interest in this respect, where H-2Dd and
Water 56.6H-2Db (not recognized by Ly-49A) differ in structural
R.m.s. deviation, angles (8) 2.0
motifs: (1) the N-terminal part of the peptide binding R.m.s. deviation, bonds (AÊ ) 0.009
cleft, where most H-2Dd complexes, irrespective of pep- R.m.s. B-factor (AÊ 2)
Main chain 1.6tide content, should be similar due to low solvent expo-
Side chain 1.3sure of the peptide; and (2) an exposed loop beneath
Ramachandran plot (%)the a2-helix. The role of these regions may be explored
Residues in most favored regions 86.9by site-directed mutagenesis.
Residues in disallowed regions 0
a Values in parentheses are calculated for the resolution intervalExperimental Procedures
6.0±2.4 AÊ .
Data Collection and Processing
Cloning, refolding, and crystallization of the MHC class I molecule
H-2Dd complexed with the HIV-1 peptide RGPGRAFVTI from the V3 made. Throughout refinement, all reflection data were used without
loop of the gp160 (sequence corresponding to HXB2R, LAI, and any s-cutoff. After simulated annealing using XPLOR (BruÈ nger,
NL43 strains; Korber et al., 1997) have already been described 1989), the model was rebuilt, where relevant. A clear difference
(Achour et al., 1998). Crystals of the H-2Dd complex belong to space electron density was observed in the peptide binding cleft, and the
group P212121 with cell dimensions a 5 51.3 AÊ , b 5 92.5 AÊ , and c 5 peptide RGPGRAFVTI could be placed unambiguously. The model
108.8 AÊ . The first data set was collected at room temperature using a was further refined by positional refinement, resulting in an Rfree of
Rigaku rotating anode. The following data collection was performed 36.8%. At this point, a new data set to 2.4 AÊ resolution collected at
under cryogenic conditions (T 5 100K), to 2.6 AÊ resolution at beam- the ESRF in Grenoble became available. The reflections for monitor-
line X11, EMBL outstation, DESY, Hamburg (l 5 0.910 AÊ ) and to 2.4 ing Rfree were kept the same as in the previous data set and refine-
AÊ resolution at beamline BM14, ESRF, Grenoble (l 5 0.900 AÊ ). In ment was continued with Refmac (Murshudov et al., 1997), including
all cases, a MAR research imaging plate system was used. The a bulk solvent correction, isotropic B factor refinement for atoms,
diffraction data was indexed with the DENZO program and scaled in and anisotropic overall B factor refinement on the reflection data.
SCALEPACK (Otwinowski, 1993). The space group was determined The mean B value resulting from the refinement, 63 AÊ 2, agrees well
with DENZO in combination with the PATTERN program (Lu, 1996). with that obtained from Wilson plots calculated for all three data
Data collection statistics for the data set used in the final refinement sets, 60, 64, and 67 AÊ 2, respectively. Water molecules were included
are presented in Table 2. manually at significant positive electron densities (3s in the Fo-Fc
map). The final rounds of refinement were carried out using data
from 20 to 2.4 AÊ yielding Rcryst 5 29.3% and Rfree 5 33.8% (27.8 andStructure Determination and Refinement
The structure of the H-2Dd complex was solved by molecular re- 32.3 in the resolution shell 6.0 - 2.4 AÊ ). In spite of these relatively
high R factors that might reflect inherent disorder in the crystals asplacement using the AMoRe program (Navaza, 1994). The H-2Kb-
OVA crystal structure (Fremont et al., 1995), with the peptide omit- indicated by their high B factors, the electron density map was of
very good quality. The overall real space correlation coefficientted, was used as a search model. The rotation andtranslation search
gave one single solution at a 5 152.958, b 5 64.258, and g 5 115.098, (Jones et al., 1991) of the model to the final 2 Fo-Fc electron density
map was 0.82. The stereochemistry of the model was analyzed withTx 5 0.166, Ty 5 0.303, and Tz 5 0.341 with a correlation coefficient
of 44.9. A rigid body refinement in XPLOR (BruÈ nger, 1989), treating PROCHECK (Laskowski et al., 1993). Solvent accessible areas were
analyzed with the programs areaimol/resarea contained in the CCP4the heavy and the b2m chains as separate units, gave an R factor
of 45.9% for data in the 8±3.0 AÊ resolution interval. The model was suite (Collaborative Computational Project No. 4, 1997). Refinement
statistics are given in Table 2.rebuilt with the amino acid sequence of H-2Dd using the O program
(Jones et al., 1991). A new data set to 2.6 AÊ resolution collected at
the EMBL outstation in Hamburg was used for further refinement. Acknowledgments
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